HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

JMV4208

a GHS-R1a receptor antagonist; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Triazoles: 1533
      - JMV4208: 1
  - Pyridines: 88
    - Picolinic Acids: 1
      - JMV4208: 1
- Heterocyclic Acids
  - Picolinic Acids: 1
    - JMV4208: 1

Experts

1.	Blayo, A L: 1 article (08/2014)
2.	Fehrentz, J A: 1 article (08/2014)
3.	Haluzík, M: 1 article (08/2014)
4.	Holubová, M: 1 article (08/2014)
5.	Jurčovičová, J: 1 article (08/2014)
6.	Lacinová, Z: 1 article (08/2014)
7.	Maletínská, L: 1 article (08/2014)
8.	Martinez, J: 1 article (08/2014)
9.	Moulin, A: 1 article (08/2014)
10.	Nagelová, V: 1 article (08/2014)

Related Diseases

1.	Obesity 08/05/2014 - "These data suggest that JMV4208 and JMV3002 could be useful therapeutic agents for the treatment of obesity."
2.	Body Weight (Weight, Body) 08/05/2014 - "Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice."

Related Drugs and Biologics

1.	Ghrelin Receptors
2.	Triazoles
3.	JMV3002